Уноси

• Therapeutic challenges in the treatment of acromegaly (2024)

  A. Marković, M. Bojic, T. Dojcinovic, D. Djekic, B. Caric, J. Malinovic Pancic, Therapeutic challenges in the treatment of acromegaly, Endocrine Abstracts (2024) 99 EP1195, 2024

• Relationship between cardiometabolic index and obesity-related complications (2025-05)

  I. Risović, M. Bojic, A. Marković, D. Djekic, L. Kos, M. Latincic, V. Banjac Baljak, D. Rakanovic, P. Arambasic, V. Skrbic, Relationship between cardiometabolic index and obesity-related complications, Obes Facts 2025;18(suppl 1):1–656, May, 2025

• Clinical characteristics and managing type 2 diabetes during COVID 19 (2022-01)

  I. Risović, D. Djekic, B. Vukovic, V. Vlatković, Clinical characteristics and managing type 2 diabetes during COVID 19, Clinical Diabetology, Vol. 11, No. 1, pp. 20 - 25, Jan, 2022

• Direct comparison two fxed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes (2023)

  I. Risović, M. Sumarac Dumanovic, M. Bojic, D. Djekic, Direct comparison two fxed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes, BMC Endocrine Disorders, Vol. 23, No. 28, pp. 1 - 6, 2023

• Benefits of insulin glargine/lixisenatide fixed-ratio combination for patients inadequately controlled on premixed insulin and oral agents (2021-09)

  I. Risović, M. Bojic, D. Djekic, Benefits of insulin glargine/lixisenatide fixed-ratio combination for patients inadequately controlled on premixed insulin and oral agents, Diabetologia 64, 1–380 (2021), Sep, 2021